Background: Cellular uptake and release of thyroid hormone are mediated by transporters. Among these, monocarboxylate transporter 8 (MCT8) shows particularly high activity towards the active thyroid hormone 3,3′,5-triiodothyronine (T3). MCT8 is expressed in different tissues, including the brain where it is predominantly localized in neurons. The MCT8 gene is located on the X chromosome. Conclusions: Mutations in MCT8 have been identified in boys with severe psychomotor retardation who also have very high serum T3 levels. Thyroid hormone is crucial for brain development, and mutations in MCT8 prevent the access of T3 to its main target cells. Thus, mutations in MCT8 represent a novel mechanism for the pathogenesis of thyroid hormone resistance.

Keywords:
Thyroid hormone, Iodothyronines, Transporter, Monocarboxylate transporter 8, Psychomotor retardation
1.
Bianco AC, Kim BW: Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 2006;116:2571–2579.
2.
Kohrle J: Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination. Best Pract Res Clin Endocrinol Metab 2007;21:173–191.
3.
Bernal J: Thyroid hormones and brain development. Vitam Horm 2005;71:95–122.
4.
Morreale de Escobar G, Obregon MJ, Escobar del Rey F: Role of thyroid hormone during early brain development. Eur J Endocrinol 2004;151(suppl 3):U25–U37.
5.
Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097–1142.
6.
Oetting A, Yen PM: New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 2007;21:193–208.
7.
Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ: Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 2001;22:451–476.
8.
Hagenbuch B: Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 2007;21:209–221.
9.
Taylor PM, Ritchie JW: Tissue uptake of thyroid hormone by amino acid transporters. Best Pract Res Clin Endocrinol Metab 2007;21:237–251.
10.
Visser WE, Friesema EC, Jansen J, Visser TJ: Thyroid hormone transport by monocarboxylate transporters. Best Pract Res Clin Endocrinol Metab 2007;21:223–236.
11.
Jansen J, Friesema EC, Milici C, Visser TJ: Thyroid hormone transporters in health and disease. Thyroid 2005;15:757–768.
12.
Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003;278:40128–40135.
13.
Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ: Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 2002;16:2283–2296.
14.
Heuer H: The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 2007;21:265–276.
15.
Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K: The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 2005;146:1701–1706.
16.
Friesema EC, Jansen J, Heuer H, Trajkovic M, Bauer K, Visser TJ: Mechanisms of disease: psychomotor retardation and high T3 levels caused by mutations in monocarboxylate transporter 8. Nat Clin Pract Endocrinol Metab 2006;2:512–523.
17.
Schwartz CE, Stevenson RE: The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract Res Clin Endocrinol Metab 2007;21:307–321.
18.
Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S: A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168–175.
19.
Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H: Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 2007;117:627–635.
20.
Fliers E, Alkemade A, Wiersinga WM, Swaab DF: Hypothalamic thyroid hormone feedback in health and disease. Prog Brain Res 2006;153:189–207.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.